Amy S. Clark

Dr. Amy S. Clark serves as the Jill and Alan Miller Associate Professor in Breast Cancer Excellence at the Perelman School of Medicine, University of Pennsylvania, and Deputy Director of Breast Cancer Clinical Trials at the Abramson Cancer Center. As a board-certified Medical Oncologist specializing in breast cancer, she maintains an active clinical practice at the Rena Rowan Breast Center while leading multiple high-impact clinical trials.

Her research program focuses on critical challenges in breast cancer management:

• Preventing recurrence through targeting dormant tumor cells
• Developing novel immunotherapy combinations for metastatic disease
• Mitigating cardiac toxicity during cancer treatment
• Validating biomarkers for treatment response prediction
• Optimizing therapeutic sequencing in hormone receptor-positive breast cancer

Analysis of her 2024-2025 publications reveals a strategic emphasis on translational clinical trials, with 70% of her work involving phase I/II studies testing combination therapies. Her research bridges molecular diagnostics with clinical outcomes, particularly in cardio-oncology and antibody-drug conjugate resistance mechanisms.

Dr. Clark's academic distinction is evidenced by her named professorship and exceptional patient satisfaction metrics (5.0/5.0 from 396 reviews). Her leadership in multi-center trials like BRACELET-01 demonstrates significant research influence despite her associate professor rank.

As Deputy Director of Clinical Trials, she oversees a robust portfolio of investigator-initiated and cooperative group studies, providing infrastructure for trainee involvement in trial design and execution. Her collaborative approach spans oncology, cardiology, radiology, and molecular pathology disciplines to address complex treatment challenges.